MediPharm Labs Faces Insolvency Risk as Q1 Losses Hit $3.3M, Warns Apollo Capital
MediPharm is Dangerously Low On Cash and is On Track to Run Out of Money by November Unless Wholesale Change Occurs MediPharm Lost Over $3.3 Million in Q1 2025 While Management Offered No Clear Plan to Achieve Profitability or Commitment to Reduce Waste or Excessive Spending Apollo Capital Warns Shareholders Not to Be Misled by…











